These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33643918)

  • 1. Globally Rare
    Oosthuizen J; Kotze MJ; Van Der Merwe N; Myburgh EJ; Bester P; van der Merwe NC
    Front Oncol; 2020; 10():619469. PubMed ID: 33643918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioneering
    Mampunye L; van der Merwe NC; Grant KA; Peeters AV; Torrorey-Sawe R; French DJ; Moremi KE; Kidd M; van Eeden PC; Pienaar FM; Kotze MJ
    Front Oncol; 2021; 11():619817. PubMed ID: 34660253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Clinically Relevant Germline
    Van der Merwe NC; Combrink HM; Ntaita KS; Oosthuizen J
    Front Genet; 2022; 13():834265. PubMed ID: 35464868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic testing in Poland and Ukraine: should comprehensive germline testing of
    Nguyen-Dumont T; Karpinski P; Sasiadek MM; Akopyan H; Steen JA; Theys D; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Stembalska A; Pesz K; Kitsera N; Siekierzynska A; Southey MC; Myszka A
    Genet Res (Camb); 2020 Aug; 102():e6. PubMed ID: 32772980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.
    Kowalik A; Siołek M; Kopczyński J; Krawiec K; Kalisz J; Zięba S; Kozak-Klonowska B; Wypiórkiewicz E; Furmańczyk J; Nowak-Ozimek E; Chłopek M; Macek P; Smok-Kalwat J; Góźdź S
    PLoS One; 2018; 13(7):e0201086. PubMed ID: 30040829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Testing for Somatic and Germline
    Peixoto A; Pinto P; Guerra J; Pinheiro M; Santos C; Pinto C; Santos R; Escudeiro C; Bartosch C; Canário R; Barbosa A; Gouveia A; Petiz A; Abreu MH; Sousa S; Pereira D; Silva J; Teixeira MR
    Front Oncol; 2020; 10():1318. PubMed ID: 32850417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
    Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
    Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First application of next-generation sequencing in Moroccan breast/ovarian cancer families and report of a novel frameshift mutation of the
    Jouali F; Laarabi FZ; Marchoudi N; Ratbi I; Elalaoui SC; Rhaissi H; Fekkak J; Sefiani A
    Oncol Lett; 2016 Aug; 12(2):1192-1196. PubMed ID: 27446417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland.
    Jasiewicz A; Rudnicka H; Kluźniak W; Gronwald W; Kluz T; Cybulski C; Jakubowska A; Lubiński J; Gronwald J
    Hered Cancer Clin Pract; 2022 Apr; 20(1):12. PubMed ID: 35382848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic trends and common BRCA1/2 pathogenic sequence variants in black African and Indian breast cancer patients presenting at Inkosi Albert Luthuli Central Hospital, KwaZulu-Natal, South Africa.
    Makhetha M; Aldous C; Chabilal N
    S Afr Med J; 2024 May; 114(6):e1094. PubMed ID: 39041507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of multigene panel testing for breast and ovarian cancer in South Africa: A step towards excellence in oncology for the public sector.
    van der Merwe NC; Ntaita KS; Stofberg H; Combrink HM; Oosthuizen J; Kotze MJ
    Front Oncol; 2022; 12():938561. PubMed ID: 36568162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients.
    Meng H; Yao L; Yuan H; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    Int J Cancer; 2020 Jun; 146(11):3044-3052. PubMed ID: 31957001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.
    Abul-Husn NS; Soper ER; Odgis JA; Cullina S; Bobo D; Moscati A; Rodriguez JE; ; ; Loos RJF; Cho JH; Belbin GM; Suckiel SA; Kenny EE
    Genome Med; 2019 Dec; 12(1):2. PubMed ID: 31892343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Novel
    Mighri N; Hamdi Y; Boujemaa M; Othman H; Ben Nasr S; El Benna H; Mejri N; Labidi S; Ayari J; Jaidene O; Bouaziz H; Ben Rekaya M; M'rad R; Haddaoui A; Rahal K; Boussen H; Boubaker S; Abdelhak S
    Front Genet; 2020; 11():552971. PubMed ID: 33240314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey.
    Demir S; Tozkir H; Gurkan H; Atli EI; Yalcintepe S; Atli E; Sezer YA; Eker D; Tuncbilek N; Tastekin E; Ozen Y; Cicin I
    J BUON; 2020; 25(3):1337-1347. PubMed ID: 32862574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.
    Cini G; Mezzavilla M; Della Puppa L; Cupelli E; Fornasin A; D'Elia AV; Dolcetti R; Damante G; Bertok S; Miolo G; Maestro R; de Paoli P; Amoroso A; Viel A
    BMC Med Genet; 2016 Feb; 17():11. PubMed ID: 26852130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel frequent BRCA1 recurrent variant c.5117G > A (p.Gly1206Glu) identified after 20 years of BRCA1/2 research in the Baltic region: cohort study and literature review.
    Loza P; Irmejs A; Daneberga Z; Miklasevics E; Berga-Svitina E; Subatniece S; Maksimenko J; Trofimovics G; Tauvena E; Ukleikins S; Gardovskis J
    Hered Cancer Clin Pract; 2021 Jan; 19(1):11. PubMed ID: 33468216
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Concolino P; Gelli G; Rizza R; Costella A; Scambia G; Capoluongo E
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
    Kluska A; Balabas A; Paziewska A; Kulecka M; Nowakowska D; Mikula M; Ostrowski J
    BMC Med Genomics; 2015 May; 8():19. PubMed ID: 25948282
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.